Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial – Contemporary Pediatrics
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial Contemporary Pediatrics Source link
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial Contemporary Pediatrics Source link
Screening for diabetes in primary care and CGM, AID advice for providers Contemporary Pediatrics Source link
Keeping up with type 1 diabetes technology changes in primary care Contemporary Pediatrics Source link
Pediatrics Supplements Market: Comprehensive Overview and Emerging Trends by 2034 openPR Source link
Expediting Screenings for Nutrition, Safety & Mental Health in Pediatrics Physician’s Weekly Source link
A Multidisciplinary Approach Improves Sexual Health Care for Youth with Duchenne Muscular Dystrophy The Journal of Pediatrics Source link
Global Pediatrics Supplements Market to Reach USD 7977.2 GlobeNewswire Source link
Testing for islet autoantibodies to monitor type 1 diabetes development Contemporary Pediatrics Source link
The Interplay of Inflammatory Bowel Disease (IBD) and Diabetes in Pediatrics: A Systematic Review Cureus Source link
How are childhood adversity profiles associated with neural function, mental health? Contemporary Pediatrics Source link